As of May 29, 2025, Odonate Therapeutics Inc (ODT) reports a Current Ratio of 5.90.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Odonate Therapeutics Inc's Current Ratio
Over recent years, Odonate Therapeutics Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2020-12-31 | 5.90 |
| 2019-12-31 | 7.42 |
| 2018-12-31 | 7.68 |
| 2017-12-31 | 27.05 |
| 2016-12-31 | 4.83 |
This gradual decrease highlights how Odonate Therapeutics Inc manages its short-term assets and liabilities over time.
Comparing Odonate Therapeutics Inc's Current Ratio to Peers
To better understand Odonate Therapeutics Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Odonate Therapeutics Inc (ODT) | 5.90 |
| Chiasma Inc (CHMA) | 9.19 |
| scPharmaceuticals Inc (SCPH) | 7.12 |
| Cocrystal Pharma Inc (COCP) | 4.77 |
| Cardiol Therapeutics Inc (CRDL.TO) | 4.52 |
| Avenue Therapeutics Inc (ATXI) | 3.26 |
Compared to its competitors, Odonate Therapeutics Inc's Current Ratio is among the highest compared to peers, indicating strong short-term financial flexibility but potentially excess cash that could be invested.